No abstract available
MeSH terms
-
Diabetes Mellitus, Type 2 / drug therapy
-
Drug Labeling* / legislation & jurisprudence
-
Drug Prescriptions / statistics & numerical data*
-
Drug Utilization / statistics & numerical data
-
Geography
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Hypoglycemic Agents / therapeutic use*
-
Rosiglitazone
-
Thiazolidinediones / adverse effects
-
Thiazolidinediones / therapeutic use*
-
United States
-
United States Food and Drug Administration
Substances
-
Hypoglycemic Agents
-
Thiazolidinediones
-
Rosiglitazone